India to France: Moxifloxacin Export Trade Route

The India to France Moxifloxacin corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $737.5K USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's moxifloxacin manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $19.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 14.8%, placing it at rank #17 among India's top moxifloxacin export destinations globally.

On the import side, key buyers of Indian moxifloxacin in France include PLANET PHARMA SA, NA, CSP VIATRIS SANTE AT CSP- LAB, and 7 others. PLANET PHARMA SA is the single largest importer with 12 shipments valued at $341.8K USD.

India's moxifloxacin exports to France are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, INDOCO REMEDIES LIMITED, MYLAN LABORATORIES LIMITED — together account for 88% of total trade value on this route. The average shipment value of $19.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as moxifloxacin tab 400mg 7bl fr via (packs 1x7s blister)(24798 packx x 1x7s=173586 nos) and apdrops dx eye drops 3ml [30280 x 1 = 30280 bottles] [moxifloxacin and dexamethasone eye drops] cont as per invoice, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PLANET PHARMA SA is the largest importer with 12 shipments worth $341.8K USD — representing 46% of all moxifloxacin imports from India on this route. A total of 10 buyers are active on this corridor.